Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hypoglycemia rates with basal insulin analogs.

Little S, Shaw J, Home P.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S53-64. doi: 10.1089/dia.2011.0022. Review.

PMID:
21668338
2.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
3.

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Treat Endocrinol. 2002;1(1):55-8. Review.

PMID:
15765621
5.

Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.

Bolli GB, Andreoli AM, Lucidi P.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S43-52. doi: 10.1089/dia.2011.0039. Review.

PMID:
21668336
6.

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.

Peterson GE.

Curr Med Res Opin. 2006 Dec;22(12):2613-9. Review.

PMID:
17166343
7.

[An update on multiple insulin injection therapy in type 1 and 2 diabetes].

Varanauskiene E, Varanauskaite I, Ceponis J.

Medicina (Kaunas). 2006;42(9):770-9. Review. Lithuanian.

8.

Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?

Valensi P, Cosson E.

Diabetes Metab. 2005 Sep;31(4 Pt 2):4S34-4S39. Review.

PMID:
16389896
9.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
10.

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.

Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2009 Apr;11(4):372-8. doi: 10.1111/j.1463-1326.2008.00976.x. Review.

PMID:
19267715
11.

Degludec: a novel basal insulin.

Kalra S, Baruah MP, Niazi AK.

Recent Pat Endocr Metab Immune Drug Discov. 2012 Jan;6(1):18-23. Review.

PMID:
22280221
12.

Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.

Duckworth W, Davis SN.

J Diabetes Complications. 2007 May-Jun;21(3):196-204. Review.

PMID:
17493554
13.

Newer insulin analogs: advances in basal insulin replacement.

Zinman B.

Diabetes Obes Metab. 2013 Mar;15 Suppl 1:6-10. doi: 10.1111/dom.12068. Review.

PMID:
23448197
14.

Insulin detemir: a long-acting insulin product.

Jones MC, Patel M.

Am J Health Syst Pharm. 2006 Dec 15;63(24):2466-72. Review. Erratum in: Am J Health Syst Pharm. 2007 Feb 15;64(4):346.

PMID:
17158694
15.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
16.

Cost-effectiveness of insulin detemir: a systematic review.

Suh DC, Aagren M.

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):641-55. doi: 10.1586/erp.11.73. Epub 2011 Oct 3. Review.

PMID:
21961796
17.

An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update).

Philis-Tsimikas A.

Expert Opin Pharmacother. 2008 Aug;9(12):2181-95. doi: 10.1517/14656566.9.12.2181 . Review.

PMID:
18671472
18.

A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.

Frier BM, Russell-Jones D, Heise T.

Diabetes Obes Metab. 2013 Nov;15(11):978-86. doi: 10.1111/dom.12106. Epub 2013 May 1. Review.

PMID:
23551900
19.

Insulin preparations with prolonged effect.

Owens DR.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S5-14. doi: 10.1089/dia.2011.0068. Review.

PMID:
21668337
20.

Flexibly timed once-daily dosing with degludec: a new ultra-long-acting basal insulin.

Josse RG, Woo V.

Diabetes Obes Metab. 2013 Dec;15(12):1077-84. doi: 10.1111/dom.12114. Epub 2013 May 6. Review.

PMID:
23577589

Supplemental Content

Support Center